Prevalence, Treatment Partners and Outcomes of Atrial Fibrillation Among Adults with Heart Failure at Bugando Medical Centre Mwanza Tanzania. (Record no. 18245)

MARC details
000 -LEADER
fixed length control field 06389nam a22003977a 4500
001 - CONTROL NUMBER
control field CUHAS/MMED/6000242/T/16
003 - CONTROL NUMBER IDENTIFIER
control field CUHAS/MMED/6000242/T/16
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240422145452.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210819b |||||||| |||| 00| 0 eng d
028 ## - PUBLISHER OR DISTRIBUTOR NUMBER
Source Wurzburg Road 35, BMC Premises, Post Code: 33102:
Source P. O Box 1464, Mwanza – Tanzania:
Source Phone: +255 28 298 3384:
Source Fax: +255 28 298 3386:
Source Email: vc@bugando.ac.tz :
Source Website: www.bugando.ac.tz
035 ## - SYSTEM CONTROL NUMBER
System control number CUHAS/MMED/6000242/T/16
040 ## - CATALOGING SOURCE
Language of cataloging English
Transcribing agency ddc
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Anikazi, Alphonce. Emmanuel
Dates associated with a name [Male]
9 (RLIN) 22446
Relator term CUHAS/MMED/6000242/T/16
210 ## - ABBREVIATED TITLE
Abbreviated title Abbreviations
Qualifying information AIDS Acquired Immunodeficiency Syndrome AF Atrial Fibrillation ACE Angiotensin-Converting enzyme ARBs Angiotensin Receptor Blockers AVNRT Atrioventricular nodal reentrant tachycardia BMC Bugando Medical Centre BMI Body Mass Index CAD Coronary Artery Disease CVD Cardiovascular Disease ESC European Society of Cardiology ECG Electrocardiography GDP Gross Domestic Product IHD Ischemic Heart Disease HF Heart Failure HFpEF Heart Failure with Preserved Ejection Fraction HFrEF Heart Failure with Reduced Ejection Fraction HTN Hypertension MNH Muhimbili National Hospital NYHA New York Heart Association MOPD Medical Outpatient Department RHD Rheumatic Heart Disease SSA Sub Saharan Africa PI Principal Investigator vAF Valvular Atrial Fibrillation nvAF Non valvular Atrial Fibrillation HF/AF Heart failure/Atrial fibrillation V-HeFT Vasodilator Heart failure trial study group VKA Vitamin K antagonist Anticoagulants NOAC Non Vitamin K Antagonist Anticoagulants CHA2DS2-VASc Congestive Heart failure, hypertension, Age ≥75 (doubled), Diabetes, Stroke (doubled), Vascular disease, Age 65–74, and Sex (female)
222 ## - KEY TITLE
Key title Operational Definitions
Qualifying information Atrial Fibrillation It is defined according to the European Society of Cardiology’s “Guideline for the Management of Atrial Fibrillation (2016)” as electrocardiogram findings, which are "irregular RR intervals and no discernible, distinct P waves."
Key title Operational Definitions
Qualifying information Heart Failure Defined by the Framingham Criteria, which requires the simultaneous presence of at least 2 major criteria or 1 major criterion in conjunction with 2 minor criteria plus NYHA functional class III/IV. The Framingham criteria are included in the appendix
Key title Operational Definitions
Qualifying information Obesity It is defined by Body Mass Index (BMI) as recommended by the World Health Organization. Underweight BMI of less than 18.5kg/m2, normal weight BMI of 18.5-24.4kg/m2, overweight BMI of 25-29.9kg/m2, and Obesity is a BMI ≥ 30kg/m2.
Key title Operational Definitions
Qualifying information Rate control
Key title Operational Definitions
Qualifying information Anemia It is defined according to the European Society of Cardiology’s “Guideline for the Management of Atrial Fibrillation (2016)” heart rate less than 110 beats/minute at rest. It is according to the WHO criteria (Gibson 1993) hemoglobin less than 13g/dl and 12g/dl for males and females, respectively.
Key title Operational Definitions
Qualifying information Per capital Income It is according to 2019 World Bank Criteria whereby annual GDP per Capital in Tanzania is 930$.
245 ## - TITLE STATEMENT
Title Prevalence, Treatment Partners and Outcomes of Atrial Fibrillation Among Adults with Heart Failure at Bugando Medical Centre Mwanza Tanzania.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Mwanza, Tanzania:
Name of publisher, distributor, etc. Catholic University of Health and Allied Sciences [CUHAS - Bugando] :
Date of publication, distribution, etc. 2020
300 ## - PHYSICAL DESCRIPTION
Extent xiv; 104 Pages
Extent Includes References and Appendices
520 ## - SUMMARY, ETC.
Summary, etc. Abstract:<br/><br/>Introduction: Atrial fibrillation (AF) and heart failure (HF) are two comorbid conditions that are discordant. The prevalence of AF is reported to increase with the advance in HF severity. Several prognostic factors for a patient with heart failure at Bugando Medical Centre (BMC) have been elaborated. Nonetheless, there was a paucity of information on the prevalence and outcomes of AF among adults with HF. This study aimed to determine the prevalence and outcomes of AF among adults with HF attending the outpatient clinic at BMC.<br/><br/>Methods: It was a hospital-based cross-sectional study with a follow-up component conducted from October 2019 to May 2020. A structured questionnaire was used to capture social demographic and clinical information. Adults with HF based on Framingham criteria underwent resting 12-lead ECG for the assessment of AF. All the study participants were followed up for three months, monitoring them for hospital admission, and mortality. Data were analyzed using STATA software version 13.<br/><br/>Results: A total of 403 adults with HF who were attending a clinic at Bugando hospital were recruited, female were 234 (58.1%) with a median age of 51-73[IQR 63] years. The prevalence of AF was 70/403 (17.4%), most was Non-valvular AF 64/70 (91.43%). Alcohol consumption and lower blood pressure below 130mmhg were found to be significant predictors for AF. The rate control strategy was administered in 53/70 (75.7%) with beta-blocker and digoxin commonly prescribed, and all participants had CHA2DS2VASC score ≥2. However, 37/70(52.9%) participants were on anticoagulant drugs, 5/70(7.1%) on Rivaroxaban, 32/70(45.7%) on warfarin, and the remaining 33/70(47.1%) were not on any anticoagulation. Among participants who ware on warfarin, only 9/32 (28.1%) achieved therapeutic INR. At three months of follow up 182/333(54.7%) patients with HF alone were hospitalized vs. 49/70(70%) with HF/AF (p-value 0.018) and death occurred 89/333 (26.7%) in HF alone vs. 31(44.3%) in those with HF/AF (p-value <0.003). AF was the only predictor of three-month mortality (p-value 0.015).<br/><br/>Conclusion: Atrial fibrillation is a prevalent problem in adults with heart failure attending the outpatient clinic at BMC, with a high rate of three-month hospital admissions and mortality. Utilization of alcohol and lower blood pressure less than 130mmhg were the main predictor for AF.<br/><br/>Recommendation: These results highlight the need to frequently screen for atrial fibrillation in heart failure patients to allow for initiation of appropriate management.<br/> <br/>
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Internal Medicine
9 (RLIN) 15587
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 19791
9 (RLIN) 20958
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type POSTGRADUATE DISSERTATIONS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   08/19/2021   PD0021 08/19/2021 08/19/2021 POSTGRADUATE DISSERTATIONS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024